Insider Stock Buying Reaches US$9.30m On Privia Health Group [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Privia Health Group, Inc. (PRVA)
Company Research
Source: Yahoo! Finance
NASDAQ:PRVA ) stock, indicating that insiders' optimism about the company's prospects has increased. Although we don't think shareholders should simply follow insider transactions, logic dictates you should pay some attention to whether insiders are buying or selling shares. Check out our latest analysis for Privia Health Group Privia Health Group Insider Transactions Over The Last Year Notably, that recent purchase by Independent Director Adam Boehler was not the only time they bought Privia Health Group shares this year. Earlier in the year, they paid US$16.43 per share in a US$9.0m purchase. So it's clear an insider wanted to buy, at around the current price, which is US$17.39. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. We do always like to see insider buying, but it is worth noting if those purchases were made at well below today's share price, as the discount to value may have
Show less
Read more
Impact Snapshot
Event Time:
PRVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PRVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PRVA alerts
High impacting Privia Health Group, Inc. news events
Weekly update
A roundup of the hottest topics
PRVA
News
- Velocity Clinical Research partners with Luminis Health, moves into oncology in the U.S. [Yahoo! Finance]Yahoo! Finance
- Privia Health Group, Inc. (NASDAQ: PRVA) was upgraded by analysts at Baird R W to a "strong-buy" rating.MarketBeat
- Privia Health to Participate in the William Blair Growth Stock ConferenceGlobeNewswire
- Privia Health Group, Inc. (NASDAQ: PRVA) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $23.00 price target on the stock.MarketBeat
- ASEAN & US Corporate Wellness Markets to 2030 | Stress Management Services Witnessing the Fastest Growth | Aduro and Vitality Group Dominate the Competition [Yahoo! Finance]Yahoo! Finance
PRVA
Earnings
- 5/9/24 - Beat
PRVA
Sec Filings
- 6/13/24 - Form 4
- 6/5/24 - Form 8-K
- 5/31/24 - Form 4
- PRVA's page on the SEC website